Genprex, Inc. (GNPX) Form 8-K — Jun 18, 2026
Genprex stockholders approved the company’s Amended and Restated 2018 Equity Incentive Plan, authorizing an additional 1.85 million shares for issuance under the plan. The amended plan is effective immediately and will remain in effect through April 15, 2036, subject to adjustments for stock splits and similar events. In a significant move to ensure compliance with Nasdaq listing requirements, stockholders authorized an amendment to the Company’s Certificate of Incorporation to effect a reverse stock split.
Key figures
- Reverse split ratio range
- 1:5 to 1:50
- Equity plan additional shares
- 1850000
- Director election votes for confer
- 877370
- Reverse split authorization expiration
- December 31, 2027
- Director election votes for moreno toscano
- 868543
Price after filing
Close on the filing date to close N calendar days later (from $0.59). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.